Assessment of the I-gel and Air-Q Supraglottic Airways as Conduits for Tracheal Intubation in Children

Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago (Other)
Overall Status
Completed
CT.gov ID
NCT02189590
Collaborator
(none)
96
1
2
2
47.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine if there is a difference in time for successful fiberoptic guided tracheal intubation through the i-gel or air-Q supraglottic airway.

Condition or Disease Intervention/Treatment Phase
  • Device: i-gel
  • Device: air-Q
N/A

Detailed Description

The goal of this randomized study is to evaluate the efficacy of the i-gel as a conduit for fiberoptic tracheal intubation when compared to the air-Q in children. Intubations will be performed by residents in training. The primary outcome is of time for successful tracheal intubation. The investigators hypothesize that residents will intubate the trachea faster when using the air-Q as compared to the i-gel. The ease of placement of the supraglottic airway device, fiberoptic grade of laryngeal view, time for device removal after intubation, and peri-operative complications will also be assessed.

Study Design

Study Type:
Interventional
Actual Enrollment :
96 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Official Title:
A Randomized Comparison of the I-gel and Air-Q as Conduits for Fiberoptic-guided Tracheal Intubation in Children
Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: air-Q

Patients will receive the air-Q with size based on manufacturer recommendations of body weight

Device: air-Q
Patients randomized to this intervention will have the air-Q placed following induction of general anesthesia. Subsequent tracheal intubation will be performed using the device as a conduit for fiberoptic-guided intubation. Following successful tracheal intubation, the device will be removed.

Experimental: i-gel

Patients will receive the i-gel with size based on manufacturer recommendations of body weight

Device: i-gel
Patients randomized to this intervention will have the i-gel placed following induction of general anesthesia. Subsequent tracheal intubation will be performed using the device as a conduit for fiberoptic-guided intubation. Following successful tracheal intubation, the device will be removed.

Outcome Measures

Primary Outcome Measures

  1. Time to Successful Tracheal Intubation [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    Time to successful tracheal intubation when using fiberoptic bronchoscopy to intubate through the i-gel or air-Q ILA. Three separate times will be measured by an independent observer: 1) Time to first glottic view: defined as the duration of time ending with the first view of the glottic opening. 2) Time to carinal view: defined as the duration of time ending with visualization of the carina. 3) Time to successful tracheal intubation: defined as the duration of time ending with the observation of a square wave end-tidal capnogram after successful tracheal intubation

Secondary Outcome Measures

  1. Ease of Placement of Supraglottic Airway [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    Ease of placement of supraglottic device ranging from 1 (easy) to 4 (difficult).

  2. Number of Attempts to Place the Supraglottic Device [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    Number of attempts will be limited to 3

  3. Supraglottic Airway Leak Pressure [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    The airway pressure at which an airway leak is observed after placement of the supraglottic airway

  4. Fiberoptic Grade of Laryngeal View [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    Fiberoptic Grade of Laryngeal View through either the air Q or i-gel will be graded using a previously published grading system

  5. Airway Maneuvers [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    The number and type of airway maneuvers performed during tracheal intubation will be recorded

  6. Postoperative Complications [Participants will be followed for the duration of anesthesia and 24 hours postoperatively]

    Complications noted postoperatively relating to the airway, such as sore throat or hoarseness.

  7. Time to Placement of Supraglottic Airway [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    Time to placement of supraglottic device will be measured.

  8. Number of Attempts to Place the Tracheal Tube [participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours]

    Number of attempts to place the tracheal tube via fiberoptic bronchoscopy through supraglottic device will be limited to 3

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Month to 6 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Children undergoing general anesthesia requiring tracheal intubation

  • Age one month to six years

Exclusion Criteria:
  • ASA class IV, V

  • Children receiving emergent surgery

  • History or high suspicion of a difficult airway

  • Active upper respiratory tract infection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Anne & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois United States 60611

Sponsors and Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

Investigators

  • Principal Investigator: Narasimhan Jagannathan, MD, Ann & Robert H Lurie Children's Hospital of Chicago / Stanley Manne Research Institute

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Narasimhan Jagannathan, Primary Investigator; MD, Ann & Robert H Lurie Children's Hospital of Chicago
ClinicalTrials.gov Identifier:
NCT02189590
Other Study ID Numbers:
  • I-gel versus air-Q
First Posted:
Jul 14, 2014
Last Update Posted:
Oct 24, 2014
Last Verified:
Oct 1, 2014
Keywords provided by Narasimhan Jagannathan, Primary Investigator; MD, Ann & Robert H Lurie Children's Hospital of Chicago

Study Results

No Results Posted as of Oct 24, 2014